Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

ConditionThyroid Associated Ophthalmopathy

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age7-90

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.

Eligibility criteria

Qualifiers

normal participants without eyelid disorders (control group)

patients with thyroid-associated ophthalmopathy (TAO group)

cooperative participants

Disqualifiers

participants with pupil or cornea disorders

participants with history of eye injury

Trial design

Treatments tested in this trial

Imaging and ocular examinations

Treatment groups

500 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Second Affiliated Hospital, School of Medicine, Zhejiang University

Lead sponsor

Source ClinicalTrials.gov